China Biologic Announces Shareholders Approval of Merger Agreement
News provided by
Share this article
Share this article
BEIJING, March 1, 2021 /PRNewswire/ China Biologic Products Holdings, Inc. (NASDAQ: CBPO, China Biologic or the Company ), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that, at an extraordinary general meeting (the EGM ) held today, the Company s shareholders voted in favor of the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of November 19, 2020 (the Merger Agreement ), among the Company, CBPO Holdings Limited ( Parent ) and CBPO Group Limited ( Merger Sub ), pursuant to which, Merger Sub will be merged with and into the Company with the Company continuing as the surviving company and becoming a wholly owned subsidiary of Parent (the Merger ), the plan of merger (the Plan of Merger ) required to be filed with the Registrar of Companies of the Cayma
China Biologic Announces Extraordinary General Meeting of Shareholders
News provided by
Share this article
Share this article
BEIJING, Jan. 25, 2021 /PRNewswire/ China Biologic Products Holdings, Inc. (NASDAQ: CBPO, China Biologic or the Company ), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that it has called an extraordinary general meeting of shareholders (the EGM ) to be held on March 1, 2021 at 10:00 a.m. (Beijing time), at the principal office of the Company located at 18th Floor, Jialong International Building, 19 Chaoyang Park Road, Chaoyang District, Beijing, China, to consider and vote on, among other matters, the proposal to authorize and approve the previously announced agreement and plan of merger, dated as of November 19, 2020 (the Merger Agreement ), among the Company, CBPO Holdings Limited ( Parent ) and CBPO Group Limited ( Merger Sub ), the plan of merger required to be filed with the Registrar of Co